⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30808849 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4011953 | 0.98 | POLB (0.52) | — | |
| SCHEMBL21604095 | 0.83 | KDM4E (0.58) | — | |
| SCHEMBL19932230 | 0.81 | CYP1A2 (0.41) | — | |
| SCHEMBL11176714 | 0.79 | MAP4K4 (0.49) | — | |
| SCHEMBL2643200 | 0.79 | — | — | |
| SCHEMBL11182769 | 0.78 | SREBF2 (0.50) | — | |
| SCHEMBL7500196 | 0.77 | — | — | |
| SCHEMBL2826538 | 0.77 | — | — | |
| SCHEMBL12844666 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102812036-A | Processes For Producing Silk Dope | COMMW SCIENT IND RES ORGANISATION | 2012-12-05 | — | — | CN | claimed |
| EP-2475677-A1 | PROCESSES FOR PRODUCING SILK DOPE | Commonwealth Scientific and Industrial Research Organisation (AU) | 2012-07-18 | — | — | EP | claimed |
| WO-2011022771-A1 | PROCESSES FOR PRODUCING SILK DOPE | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) | 2011-03-03 | — | — | WO | claimed |
| US-20060052636-A1 | Method for the production of acylphosphine oxides | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | claimed |
| EP-1546163-A1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-29 | — | — | EP | claimed |
| WO-2004029063-A1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-08 | — | — | WO | claimed |
| US-20260001871-A1 | TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D | ESCIENT PHARMACEUTICALS INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250268919-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER | AMNEAL PHARMACEUTICALS LLC | 2025-08-28 | — | — | US | disclosed |
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| CN-118871116-A | Compounds for the treatment of cancer | 卡希夫生物科学有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4444318-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER | Kashiv Biosciences, LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| US-20240261274-A1 | TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-08-08 | — | — | US | disclosed |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| CN-1239478-A | 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor | SUNTORY LTD (JP) | 1999-12-22 | — | — | CN | disclosed |
| US-5877322-A | Substituted pyridines, their preparation, and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1999-03-02 | — | — | US | disclosed |
| CN-1130900-A | Substituted pyridines, their preparation and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1996-09-11 | — | — | CN | disclosed |
| EP-0719257-A1 | SUBSTITUTED PYRIDINES, PROCESS FOR PRODUCING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | Hoechst Schering AgrEvo GmbH (DE) | 1996-07-03 | — | — | EP | disclosed |
| WO-1995007892-A1 | SUBSTITUTED PYRIDINES, PROCESS FOR PRODUCING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1995-03-23 | — | — | WO | disclosed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | disclosed |
| US-5308843-A | Method of inhibiting mammalian topoisomerase II and malignant cell growth in mammals, with substituted (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4 ]-benzoxazine(and-benzothiazine)-6-carboxylic acids | STERLING DRUG INC. (US) | 1994-05-03 | — | — | US | disclosed |